Biosimulation Market - Forecasts from 2018 to 2023

Biosimulation Market - Forecasts from 2018 to 2023

Biosimulation is used in the healthcare sector for model-based calculation of biological systems. It is helpful in making commercial decisions regarding the benefits of bringing a specific drug to market. In 2022, the market for biosimulation is expected to reach US$3,435 million, increasing from US$1,476 million in 2017, at a CAGR of 18.40%. Factors driving the biosimulation market growth are increased medical research and development across emerging economies, technological advancement in drug development processes, robust pace of clinical trials and a favorable regulatory environment in developed regions like the US and Europe. Rising demand for reduced drug development costs coupled with penetration of digital and computer technology and improvement in modeling tools has fuelled further market growth. Geographically, North America is the expected to remain the largest biosimulation market over the projected period followed by Europe.

Research Methodology

The first section of the report deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.

Market Dynamics

Next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook, key industry and regional regulations which are determining the product specifications and a brief technological aspect of Biosimulation. Complete industry analysis has also been covered by Porter’s five forces model as a part of this report section.


The Biosimulation market has been segmented by type, applications, end-user industry and geography.

By Type:



By Application:

Drug Development

Drug Discovery


By End-User Industry:

Pharmaceutical Companies

Academic Institutions

Research Organizations


By Geography:


North America

South America

Europe Middle East & Africa


The Middle East & Africa

Asia Pacific

Market Players

Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players in the Biosimulation market are Certara USA, Inc., Advanced Chemistry Development, Inc., Schrodinger, LLC and Simulations Plus among others.

1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1. Segmentation
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Supplier Outlook
4.6. Industry Outlook
4.7. Porter’s 5 Forces Analysis
4.8. Industry Value Chain Analysis
4.9. Scenario Analysis
5. Biosimulation Market Forecast by Type (US$ million)
5.1. Software
5.2. Services
6. Biosimulation Market Forecast by Application (US$ million)
6.1. Drug Development
6.2. Drug Discovery
6.3. Others
7. Biosimulation Market Forecast by End-User Industry (US$ million)
7.1. Pharmaceutical Companies
7.2. Academic Institutions
7.3. Research Organizations
7.4. Others
8. Biosimulation Market Forecast by Geography (US$ million)
8.1. Americas
8.1.1. North America
8.1.2. South America
8.2. Europe Middle East and Africa
8.2.1. Europe
8.2.2. Middle East and Africa
8.3. Asia Pacific
9. Competitive Intelligence
9.1. Market Share of Key Players
9.2. Investment Analysis
9.3. Recent Deals
9.4. Strategies of Key Players
10. Company Profiles
10.1. Certara USA, Inc.
10.2. Advanced Chemistry Development, Inc.
10.3. Schrodinger, LLC
10.4. Simulations Plus
10.5. Chemical Computing Group Inc.
10.6. Dassault Systemes BIOVIA
10.7. In Silico Biosciences, Inc.
10.8. InhibOx Ltd
10.9. LeadInvent Technologies Pvt. Ltd.
10.10. Genedata AG
10.11. Physiomics PLC

Certara USA, Inc.

Advanced Chemistry Development, Inc.

Schrodinger, LLC

Simulations Plus

Chemical Computing Group Inc.

Dassault Systemes BIOVIA

In Silico Biosciences, Inc.

InhibOx Ltd

LeadInvent Technologies Pvt. Ltd.

Genedata AG

Physiomics PLC

  • SKU:
  • Publishing Date: 2018-04-11
  • Product Code: 1
  • Availability: In Stock
  • $4,200.00
  • Ex Tax: $4,200.00

Available Options